{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:39:25Z","timestamp":1791383965402,"version":"4.3.3"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clinbiochem.2021.01.009","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T11:24:07Z","timestamp":1612178647000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS\/MS and immunoassays"],"prefix":"10.1016","volume":"90","author":[{"given":"Mikael","family":"Lindstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mink","family":"Schinkelshoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti J.","family":"Tienari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyrki P.","family":"Kukkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto","family":"Renkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fronczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert Jan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Itkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2021.01.009_b0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.clinbiochem.2021.01.009_b0010","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.01.009_b0015","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1152\/ajpcell.00227.2012","article-title":"Physiology of the orexinergic\/hypocretinergic system: a revisit in 2012","volume":"304","author":"Kukkonen","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.01.009_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.smrv.2008.05.002","article-title":"Hypocretin\/orexin disturbances in neurological disorders","volume":"13","author":"Fronczek","year":"2009","journal-title":"Sleep Med. Rev."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.01.009_b0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"issue":"9197","key":"10.1016\/j.clinbiochem.2021.01.009_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2021.01.009_b0035","doi-asserted-by":"crossref","unstructured":"M.J. Sateia, International Classification of Sleep Disorders-Third Edition. Chest 2014 11\/01; 2019\/08;146(5):1387-1394.","DOI":"10.1378\/chest.14-0970"},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.01.009_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.clinbiochem.2021.01.009_b0045","doi-asserted-by":"crossref","unstructured":"Nishino S. Hypocretin Measurements in the CSF, and Blood and Brain Tissue. Basic and Clinical Applications. In: Nishino,S., Sakurai,T., editor. The Orexin\/Hypocretin System. Contemporary Clinical Neuroscience Totowa, NJ, USA: Humana Press; 2006. p. 73-82.","DOI":"10.1385\/1-59259-950-8:71"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.01.009_b0050","doi-asserted-by":"crossref","first-page":"25162","DOI":"10.1038\/srep25162","article-title":"From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid","volume":"11","author":"Hirtz","year":"2016","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.clinbiochem.2021.01.009_b0055","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1021\/acs.analchem.9b02710","article-title":"Considerably Lower Levels of Hypocretin-1 in Cerebrospinal Fluid Is Revealed by a Novel Mass Spectrometry Method Compared with Standard Radioimmunoassay","volume":"91","author":"B\u00e5rdsen","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.clinbiochem.2021.01.009_b0060","unstructured":"International classification of sleep disorders. 3rd ed. Darien, IL, USA: American Academy of Sleep Disorders.; 2014."},{"key":"10.1016\/j.clinbiochem.2021.01.009_b0065","unstructured":"The international classification of sleep disorders : diagnostic and coding manual ; (ICSD). 2nd ed. Westchester, IL, USA: American Academy of Sleep Medicine; 2005."},{"issue":"12","key":"10.1016\/j.clinbiochem.2021.01.009_b0070","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.01.009_b0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jsr.12130","article-title":"CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis?","volume":"23","author":"Liguori","year":"2014","journal-title":"J. Sleep Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.01.009_b0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/nbdi.2001.0389","article-title":"Hypocretin levels in sporadic and familial cases of canine narcolepsy","volume":"8","author":"Ripley","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.01.009_b0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.74.1.127","article-title":"Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia","volume":"74","author":"Ebrahim","year":"2003","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.01.009_b0090","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.5665\/sleep.2114","article-title":"Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions","volume":"35","author":"Dauvilliers","year":"2012","journal-title":"Sleep"},{"issue":"13","key":"10.1016\/j.clinbiochem.2021.01.009_b0095","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1523\/JNEUROSCI.22-13-05282.2002","article-title":"Release of hypocretin (orexin) during waking and sleep states","volume":"22","author":"Kiyashchenko","year":"2002","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.01.009_b0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36942-8","article-title":"HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy","volume":"9","author":"Sakai","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.clinbiochem.2021.01.009_b0105","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.56.12.1749","article-title":"Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients","volume":"56","author":"Dalal","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.clinbiochem.2021.01.009_b0110","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/pcn.12780","article-title":"Measurement of cerebrospinal fluid orexin-A (hypocretin-1) by enzyme-linked immunosorbent assay: A comparison with radioimmunoassay","volume":"72","author":"Ono","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.01.009_b0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/00365513.2017.1325928","article-title":"Hypocretin measurement: shelf age of radioimmunoassay kit, but not freezer time, influences assay variability","volume":"77","author":"Keating","year":"2017","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.01.009_b0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.01.009_b0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.clinbiochem.2021.01.009_b0130","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"Mignot","year":"1997","journal-title":"Sleep"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:56:57Z","timestamp":1757865417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":26,"alternative-id":["S0009912021000254"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.01.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS\/MS and immunoassays","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}